Search research articles
Contact Us
Filters
Showing results (81-90 of 202) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2019
Review of Current Policy Strategies to Reduce US Cancer Drug Costs
Angela K Green, Jennifer A Ohn, Peter B Bach
JAMA
|
October 5, 2017
FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug
Peter B Bach, Sergio A Giralt, Leonard B Saltz
Annals of Internal Medicine
|
July 17, 2013
Computed tomography screening for lung cancer
Peter B Bach, Michael K Gould, Gerard A Silvestri
Pharmacoeconomics - Open
|
December 14, 2020
Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir's Value
Michaela R Anderson, Peter B Bach, Matthew R Baldwin
Medical Care
|
February 12, 2022
The Prescription Drug User Fee Act: Much More Than User Fees
Aaron P Mitchell, Niti U Trivedi, Peter B Bach
The Lancet. Oncology
|
March 7, 2018
Low-dose CT for lung cancer screening
Peter B Bach, Otis W Brawley, Gerard A Silvestri
JAMA
|
April 15, 2004
Lung cancer in US women: a contemporary epidemic
Jyoti D Patel, Peter B Bach, Mark G Kris
Chest
|
January 16, 2003
Screening for lung cancer: the guidelines
Peter B Bach, Dennis E Niewoehner, William C Black, et al.
JAMA
|
November 2, 2018
Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model"
Mark R Trusheim, William M Cassidy, Peter B Bach
Health Affairs (Project Hope)
|
March 9, 2011
Episode-based payment for cancer care: a proposed pilot for Medicare
Peter B Bach, Joshua N Mirkin, Jason J Luke
Page
of 21
Search research articles
Search
Showing results (81-90 of 202) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2019
Review of Current Policy Strategies to Reduce US Cancer Drug Costs
Angela K Green, Jennifer A Ohn, Peter B Bach
JAMA
|
October 5, 2017
FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug
Peter B Bach, Sergio A Giralt, Leonard B Saltz
Annals of Internal Medicine
|
July 17, 2013
Computed tomography screening for lung cancer
Peter B Bach, Michael K Gould, Gerard A Silvestri
Pharmacoeconomics - Open
|
December 14, 2020
Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir's Value
Michaela R Anderson, Peter B Bach, Matthew R Baldwin
Medical Care
|
February 12, 2022
The Prescription Drug User Fee Act: Much More Than User Fees
Aaron P Mitchell, Niti U Trivedi, Peter B Bach
The Lancet. Oncology
|
March 7, 2018
Low-dose CT for lung cancer screening
Peter B Bach, Otis W Brawley, Gerard A Silvestri
JAMA
|
April 15, 2004
Lung cancer in US women: a contemporary epidemic
Jyoti D Patel, Peter B Bach, Mark G Kris
Chest
|
January 16, 2003
Screening for lung cancer: the guidelines
Peter B Bach, Dennis E Niewoehner, William C Black, et al.
JAMA
|
November 2, 2018
Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model"
Mark R Trusheim, William M Cassidy, Peter B Bach
Health Affairs (Project Hope)
|
March 9, 2011
Episode-based payment for cancer care: a proposed pilot for Medicare
Peter B Bach, Joshua N Mirkin, Jason J Luke
Page
of 21